Clinical Genetics in Reproductive Medicine: Variant Classification, Medically Actionable Genes, and Carrier Screening
Seminars in Reproductive Medicine · 01.12.2025 · 43 (04) · 243-253
DOI: 10.1055/a-2781-8392 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Seminars in Reproductive Medicine, erschienen am 01.12.2025. Verfasst von Anastasia Navitski und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, Medical College of Georgia at Augusta University, Augusta, Georgia. Hauptthemen laut MEDLINE: Reproductive Medicine, Genetic Testing, Genetic Carrier Screening, Genetic Variation.
Abstract (Originalsprache)
AbstractAs genomic sequencing becomes more prevalent in reproductive medicine, clinicians must remain knowledgeable about the purpose of each ordered test, the principles of variant classification, and how to interpret and integrate findings into clinical decision-making. This review outlines the American College of Medical Genetics and Genomics (ACMG) standardized guidelines for sequence variant interpretation and highlights anticipated updates in the forthcoming v4.0 framework. When next-generation sequencing is performed for a clinical condition, incidental findings of pathogenic and likely pathogenic variants in medically actionable genes (MAGs) may be identified. Conditions included on the ACMG MAG list are typically highly penetrant, primarily autosomal dominant or X-linked, and have established interventions that can alter disease trajectory. Carrier screening enables the identification of autosomal recessive and X-linked variants in prospective parents that predispose them to genetic disease in their children. The ACMG's tier-based recommendations support universal Tier 3 screening, targeting conditions with a carrier frequency of at least 1 in 200 and moderate/severe phenotypes, while Tier 4 screening is reserved for individuals with consanguinity or significant family history. While technical genomic advances enhance the delivery of precision medicine, they introduce challenges, including higher rates of uncertain findings and the need for more careful clinical interpretation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Obstetrics and Gynecology, Medical College of Georgia at Augusta University, Augusta, Georgia.
- Section of Reproductive Endocrinology, Infertility, and Genetics, Medical College of Georgia at Augusta University, Augusta, Georgia.
- Department of Neuroscience and Regenerative Medicine, Medical College of Georgia at Augusta University, Augusta, Georgia.
ORCID-Profile: Anastasia Navitski
Zitieren
APA
Navitski, A., & Layman, L. C. (2025). Clinical Genetics in Reproductive Medicine: Variant Classification, Medically Actionable Genes, and Carrier Screening. Seminars in Reproductive Medicine, 43(04), 243-253. https://doi.org/10.1055/a-2781-8392
Vancouver
Navitski A, Layman LC. Clinical Genetics in Reproductive Medicine: Variant Classification, Medically Actionable Genes, and Carrier Screening. Seminars in Reproductive Medicine. 2025;43(04):243-253. doi:10.1055/a-2781-8392
BibTeX
@article{Navitski2025,
author = {Navitski, Anastasia and Layman, Lawrence C},
title = {Clinical Genetics in Reproductive Medicine: Variant Classification, Medically Actionable Genes, and Carrier Screening},
journal = {Seminars in Reproductive Medicine},
year = {2025},
volume = {43},
number = {04},
pages = {243--253},
doi = {10.1055/a-2781-8392}
}
EUVIMED